Logo

ASTAL LABORATORIES LIMITED Share Price

BSE: 512600
|
Trading
₹ 85.18
-₹2.72 (-3.09%)
1D
Last updated 03 Jul, 2026, 15:40 IST

ASTAL LABORATORIES LIMITED Share Price Today

As of 5 Jul 2026, ASTAL LABORATORIES LIMITED share price is ₹85.18. The stock opened at ₹87.99, compared to its previous close of ₹87.90. During today's trading session, ASTAL LABORATORIES LIMITED share price moved in the range of ₹82.00 to ₹89.97, with an average price of ₹85.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.45 and a high of ₹103.20.

₹82.00
3.09% down today
₹89.97
1D LOW
1D HIGH

ASTAL LABORATORIES LIMITED Returns Calculator

Open
₹87.99
High
₹89.97
Low
₹82.00
Prev. close
₹87.90
Circuit
L
H
₹68.15
₹102.21
52-week
L
H
₹60.45
₹103.20

ASTAL LABORATORIES LIMITED Shareholder Returns

ASTAL LABORATORIES LIMITED Share Price History

Mkt Cap Cr
384.99
P/E
47.51
P/B
1.15
ROE
2.48%
D/E
0.04
ROCE
3.61%
Div. Yield
0.00%
EPS(TTM)
4.76
Turnover
0.47
EV/EBITDA
30.69
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.03%
Quick Ratio
0.00
Curr. Ratio
1.74
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Astal Lab outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Astal Lab appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Astal Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

ASTAL LABORATORIES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2026
Revenue64.36249.35
Operating profit11.9817.73
Net profit8.9314.71

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹64.23₹23.65₹3.43₹0.00
Other Income₹0.13₹0.01₹0.18₹0.21
Total Revenue₹64.36₹23.66₹3.61₹0.21
Total Expenses₹52.38₹22.57₹3.57₹0.23
Profit Before Tax₹11.98₹1.09₹0.03-₹0.02
Tax₹3.05₹0.30₹0.02₹0.00
Profit After Tax₹8.93₹0.78₹0.02-₹0.02
EPS - Basic₹9.08₹1.55₹0.04-₹0.04
EPS - Diluted₹8.04₹1.55₹0.04-₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹11.98₹1.09₹0.03-₹0.02
Income before WC changes₹12.78₹1.11-₹0.14-₹0.21
Change in Assets-₹23.36-₹14.62-₹5.95₹0.03
Change in Liabilities-₹1.63₹7.96₹4.66-₹0.06
Change in WC-₹24.99-₹6.66-₹1.29-₹0.04
Cash flow from Operations-₹12.52-₹5.58-₹1.44-₹0.25
Cash flow from Investing-₹7.81-₹6.11₹1.50₹0.24
Cash flow from Financing₹3.29₹17.68₹0.00₹0.00
Total Cash Flow-₹17.04₹5.99₹0.07-₹0.01
Cash (Start of the year)₹6.08₹0.08₹0.02₹0.03
Cash (End of the year)-₹10.96₹6.08₹0.08₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹17.70₹9.89₹3.79₹5.13
Current Assets₹45.64₹26.73₹6.11₹0.10
Total Assets₹63.34₹36.61₹9.91₹5.23
Current Liabilities₹26.77₹13.01₹4.73₹0.07
Net Current Asset₹18.87₹13.72₹1.38₹0.03
Non-Current Liabilities₹0.57₹0.26₹0.00₹0.00
Equity Capital₹35.99₹23.34₹5.18₹5.16
Total Equity & Liabilities₹63.34₹36.61₹9.91₹5.23
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
84.8
36
84.98
21
85
130
85.18
465
0
0
Bid Total: 0
Ask Total: 652
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.49
Neutral
ATR (14)
5.08
Neutral
STOCH(9,6)
56.87
Neutral
STOCH RSI (14)
44.23
Neutral
ADX(9)
39.54
Bearish
UO(9)
51.69
Neutral
ROC(12)
2.89
Bullish
WillR(14)
-41.63
Neutral
Period
Simple value
Exponential vaue
5D
87.53
86.36
10D
84.39
84.83
20D
80.89
81.92
50D
75.42
77.82
100D
74.6
77.66

About ASTAL LABORATORIES LIMITED

ASTAL LABORATORIES LIMITED logo
ISIN
INE307N01014
Sector Market Cap
₹ 384.99 Cr

Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.

ASTAL LABORATORIES LIMITED Financial Highlights

  • Revenue: ASTAL LABORATORIES LIMITED reported revenue of ₹249.35 crore in FY26 vs ₹64.36 crore in FY25. It showed an increase of 287.43% on a yearly basis.
  • Operating Profit: ASTAL LABORATORIES LIMITED reported an operating profit of ₹17.73 crore in FY26 vs ₹11.98 crore in FY25. It showed an increase of 48.00% on a year-on-year basis.
  • Net Profit: ASTAL LABORATORIES LIMITED reported a net profit of ₹14.71 crore in FY26 vs ₹8.93 crore in FY25. It showed an increase of 64.73% on a yearly basis.

ASTAL LABORATORIES LIMITED Quarterly Result Highlights

  • ASTAL LABORATORIES LIMITED reported revenue of ₹134.15 crore in Mar 2026, compared with ₹52.28 crore in Dec 2025, representing an increase of 156.60% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported an operating profit of ₹8.34 crore in Mar 2026, compared with ₹3.13 crore in Dec 2025, representing an increase of 166.45% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported a profit of ₹7.68 crore in Mar 2026, compared with ₹2.36 crore in Dec 2025, reflecting an increase of 225.42% on a QoQ basis.
Know more
Promoters
4.53%
FII
0.00%
Other DII
0.00%
Retail and other
95.47%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
ASTAL LABORATORIES LIMITED logo
ASTAL LABORATORIES LIMITED
Trading
Add Stock
Add Another

FAQs on ASTAL LABORATORIES LIMITED Share Price